IntroductionIntroductionQelbree (viloxazine hydrochloride) is a relatively new prescription medication for Attention-Deficit Hyperactivity Disorder (ADHD). Approved by the FDA in 2021, it offers a non-stimulant option for treating ADHD in children (ages 6 and up), adolescents, and adults. This medication provides an alternative for individuals who cannot tolerate stimulant-based medications or are concerned about stimulant-related side …